Blaztere 4 mg Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Blaztere 4 mg Injection belongs to a group of medicines called bisphosphonates and contains zoledronic acid. Its labelling describes it for the treatment of bone complications such as fractures and bone metastasis in adults (where cancer spreads from the original tumour to the bone), and for reducing the level of calcium in the blood of adult patients (tumour-induced hypercalcemia). It is described as suppressing the activity of osteoclasts — the cells that cause bone destruction — which helps strengthen bone and lowers the risk of fractures. It is administered intravenously by a healthcare provider.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of bone complications such as fractures in adults
- Described for the treatment of bone metastasis in adults
- Described for reducing the amount of calcium in the blood (tumour-induced hypercalcemia)
- Described as suppressing osteoclast activity to strengthen bone and lower fracture risk
Described Dosage & Administration
- Taken only if prescribed by the doctor
- Administered intravenously by a healthcare provider or doctor
- The doctor prescribes the dose and duration depending on the patient’s condition
Described Side Effects
Described common side effects include headache, conjunctivitis, flu-like symptoms, low red blood cell count, low blood phosphate, nausea, and vomiting. Less common and rare effects are also described:
- Uncommon: allergic reaction, dizziness, difficulty breathing, weight gain, high or low blood pressure, urticaria
- Rare: slow heartbeat, unusual fracture of the thigh bone, joint swelling, swelling of the eyes
A doctor should be consulted immediately for severe kidney problems, bone damage in the jaw, swellings or painful sores in the mouth or jaw, irregular heartbeat, severe allergic reaction, or reduced blood calcium. Most effects are described as not persisting for long.
Precautions
- Taken only if prescribed by the doctor
- Administered intravenously by a healthcare provider
- Severe kidney problems, jaw bone damage, mouth or jaw sores, irregular heartbeat, severe allergic reaction, or low blood calcium after use should be reported to the doctor immediately
- Kept out of the reach of children
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains zoledronic acid and is used for bone complications such as fractures, bone metastasis in adults, and tumour-induced hypercalcemia. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as administered intravenously by a healthcare provider or doctor, only if prescribed, with the dose and duration set by the doctor.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.